Showing 131 - 140 of 377
Persistent link: https://www.econbiz.de/10002565280
Persistent link: https://www.econbiz.de/10002565330
Persistent link: https://www.econbiz.de/10002565353
I look at prevention through an economic lens and make three main points. First, those advocating preventive measures are often asked how much money a given measure saves. This question is misguided. Rather preventive measures can be thought of as insurance, with a certain cost in the present...
Persistent link: https://www.econbiz.de/10012481408
I describe several changes to Medicare in the 1990s, their rationale, and their likely effects. I focus principally on issues in the administered price systems Medicare uses to pay medical providers, especially those used for post-acute care providers, Health Maintenance Organizations (HMOs),...
Persistent link: https://www.econbiz.de/10012470187
Persistent link: https://www.econbiz.de/10013480547
In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important federal legislation, institutional details regarding distribution channel logistics, definitions of alternative price measures, related historical...
Persistent link: https://www.econbiz.de/10010549907
Medicare continues to implement payment reforms that shift reimbursement from fee-for-service towards episode-based payment, affecting average and marginal reimbursement. We contrast the effects of two reforms for home health agencies. The Home Health Interim Payment System in 1997 lowered both...
Persistent link: https://www.econbiz.de/10010796285
Persistent link: https://www.econbiz.de/10002453016
This paper examines the causes and consequences of reductions in cardiovascular disease mortality, and in particular heart attack mortality, over the past several decades. Analysis of data from Medicare and review of the clinical literature indicate that a large share of the recent decline in...
Persistent link: https://www.econbiz.de/10012472290